Bright Minds Biosciences (DRUG) Cash Flow: Operating & Free Cash Flow

Bright Minds Biosciences Cash Flow Statement Analysis

Values in millions CAD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Bright Minds Biosciences Inc. (DRUG) - Annual data in millions CAD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Sep 2025	Dec 2024	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019
Operating Activities
Net Income	-12.23	-2.80	-2.80	-7.37	-14.96	-8.65	-0.48	-0.08
Depreciation & Amortization	0.08	0.07	0.07	0.07	0.01	0.00	0.00	0.00
Stock Based Compensation	3.18	0.84	0.84	1.15	0.90	0.88	0.16	0.00
Change in Working Capital	0.55	0.04	0.04	-0.94	0.72	0.31	0.03	0.04
Change in Accounts Receivable	-0.36	-0.01	-	0.12	-0.05	-0.11	0.00	0.00
Change in Accounts Payable	0.00	0.00	0.24	-1.20	0.77	0.51	0.00	0.00
Change in Other Working Capital	0.92	0.05	-0.20	0.02	-0.04	-0.20	0.03	0.04
Other Operating Activities	-0.28	0.00	0.00	0.02	-0.26	0.14	0.16	0.11
Net Cash from Operating Activities	-8.69	-1.85	-1.85	-7.02	-13.59	-7.32	-0.29	-0.04
Investing Activities
Net Cash from Investing Activities	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Financing Activities
Debt Repayment	-0.10	-0.09	-0.09	-0.09	-0.01	0.00	0.00	0.00
Common Stock Issued	86.03	0.90	0.90	1.22	6.00	27.84	1.01	0.12
Other Financing Activities	-0.36	0.00	-	-0.03	-0.80	-1.79	0.00	0.37
Net Cash from Financing Activities	85.57	0.81	0.81	2.19	5.20	26.06	1.01	0.12
Summary
Effect of Forex Changes on Cash	0.31	0.01	0.01	-0.05	0.26	0.22	0.00	0.00
Net Change in Cash	77.19	-1.03	-1.03	-4.83	-8.13	18.96	0.72	0.08
Cash at Beginning of Period	5.72	6.75	6.75	11.63	19.76	0.80	0.08	0.00
Cash at End of Period	82.91	5.72	5.72	6.75	11.63	19.76	0.80	0.08
Free Cash Flow	-8.69	-1.85	-1.85	-7.02	-13.59	-7.32	-0.29	-0.04

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bright Minds Biosciences Cash Flow

What is Bright Minds Biosciences's free cash flow?

Bright Minds Biosciences had negative free cash flow of CAD 8.69M in fiscal 2025 (fiscal year ended Sep 30, 2025).

Does Bright Minds Biosciences pay dividends or buy back shares?

Bright Minds Biosciences's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition